Quietmind Foundation

  • About
  • Services
    • Medical Marijuana
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
    • Cosmetic Study of Wrinkles
  • Research
  • Equipment
  • Blog

Leading Edge Commentary

Vascular Health and Dementia Update

8/24/2020

0 Comments

 
This article shows current findings related to cerebrovascular reactivity(CVR) as a marker for dementia onset and progression. We've been promoting photobiomodulation with both the Cognitolite, Vielight and other LLLT devices as a means of decreasing vascular reactivity which in our case we've referred to as 'vascular inflexibility'. Not unlike how the healthy flexibility of the cardiac rhythm is undermined by various factors that lead to infarcts and other problems, we see cerebral vasculature as being susceptible to similar challenges. Neurofeedback training will help sustain the improved level of functioning by optimizing cortical electrical functions that will help improve vascular responsiveness.

https://www.psychiatryadvisor.com/home/topics/neurocognitive-disorders/alzheimers-disease-and-dementia/cerebrovascular-reactivity-predicts-cognitive-impairment-independent-of-ad/?utm_source=newsletter&utm_medium=email&utm_campaign=pa-update-hay-20200824&cpn=&hmSubId=6Qh5EgxRQ0A1&hmEmail=VFLBRZ7KAOgTOytGd7O2WyfFDtHnYy33zUsxQGbtptc1&NID=&email_hash=24523e9d8526aea879f1cbe868535f18&mpweb=1323-102963-6650987
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Our mission is to study, provide and promote drug-free, low-cost, noninvasive approaches to understanding and treating disorders that affect people's thinking, behavior, and movement.


Office Hours

Monday & Thursday: 11am - 6pm
In-office and
​remote conferencing available

Locations

Main Office- PA
​8120 Old York Road, Suite 140
Elkins Park, PA 19027

New York Office
1619 3rd Ave. Suite 202 New York, NY 10128
​
(clinical trial evaluation only)

Telephone Number

610-940-0488

Fax Number

215-359-0630

Email

info@quietmindfdn.org

Support Us

QuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need help.
© 2020 Quietmind Foundation | All Rights Reserved | Quietmind Foundation is a not-for-profit 501(c)(3) organization.
  • About
  • Services
    • Medical Marijuana
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
    • Cosmetic Study of Wrinkles
  • Research
  • Equipment
  • Blog